510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

BD MAX Enteric Parasite Panel, BD MAX Instrument

K143648510(k) TraditionalCleared Aug 25, 2015246-day reviewClass II21 CFR 866.3990Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson and Company · PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System

Cleared on Aug 25, 2015 as substantially equivalent to K140407 (Biofire Diagnostics, 2014) after a 246-day review. Its family tree reaches back 2 generations to 2013. 2 later devices descend from it. It has been recalled once.

Decided
Aug 25, 2015
Review
246 days
Class
Class II
Product code
PCH
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to DEN130003 (2013). 2 later devices descend from it, 2 citing it directly.

  1. Root · 2 generations backDEN130003 Xtag Gastrointestinal Pathogen Panel (GPP) Xtag Data Analysis…Luminex Molecular Diagnostics, Inc. · 2013
  2. 1 generation backK140407 Filmarray Gastrointestinal (GI) PanelBiofire Diagnostics · 2014 · Recalled
  3. This deviceK143648 BD MAX Enteric Parasite Panel, BD MAX InstrumentBecton, Dickinson and Company · 2015
  4. Descendant · cites it directly · 0 of its ownK232672 EasyScreen Gastrointestinal Parasite Detection KitGenetic Signatures Limited · 2024
  5. Descendant · cites it directly · 0 of its ownK220193 BD MAX Enteric Parasite PanelBecton, Dickinson and Company · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K232672EasyScreen Gastrointestinal Parasite Detection KitGenetic Signatures Limited · 2024 · cites it directly0descendants
  • K220193BD MAX Enteric Parasite PanelBecton, Dickinson and Company · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN130003Xtag Gastrointestinal Pathogen Panel (GPP) Xtag Data Analysis Software for GPP…Luminex Molecular Diagnostics, Inc.2013—
−1K140407Filmarray Gastrointestinal (GI) PanelBiofire Diagnostics20148
0 (this device)K143648BD MAX Enteric Parasite Panel, BD MAX InstrumentBecton, Dickinson and Company2015—
+1K232672EasyScreen Gastrointestinal Parasite Detection KitGenetic Signatures Limited2024—
+1K220193BD MAX Enteric Parasite PanelBecton, Dickinson and Company2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202410
FIG. 1 — Lineage of K143648, 2013–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PCH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PCH device

  1. #1 K220062 QIAstat-Dx Gastrointestinal Panel 2score 16.7 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140407Filmarray Gastrointestinal (GI) Panel
Summary page 5
…y (83) Product Code(s): PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System Predicate Device FilmArray Gastrointestinal (GI) Panel Kit [K140407 (May 2, 2014)], BioFire Diagnostics, LLC Device Establishment GeneOhm Sciences Canada, Inc. (BD Diagnostics) 2555 Boul. du Parc…
Biofire Diagnostics20148

Also cleared against K140407: 7 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K232672EasyScreen Gastrointestinal Parasite Detection KitGenetic Signatures Limited20240
K220193BD MAX Enteric Parasite PanelBecton, Dickinson and Company20220

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 17, 2019Class IIZ-2329-2019Process controlThe foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 3 companies; a new generation was cleared every 1.3 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K232672 (Genetic Signatures Limited, 2024) has gone furthest, with 0 descendants of its own.
  • 7 other devices also cite its predicate K140407.

How does its category compare?

All PCH devices

PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · PCH

7in 2025

2013: 32014: 62015: 22016: 22017: 12018: 42019: 42022: 22023: 12024: 32025: 72026 (partial year): 3
2007high 7 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PCH

89in 2025

2014: 120 days median2018: 105 days median2019: 191 days median2024: 271 days median2025: 89 days median2026 (partial year): 176 days median
2007high 271 (2024) · low 89 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PCH

5in 2025

2023: 12025: 5
2007high 5 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PCH

40in 2025

2014: 12019: 42021: 262022: 472023: 622024: 452025: 40
2007high 62 (2023) · low 0 (2007)2025

MAUDE reports naming product code PCH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20133—00
2014612001
20152—00
20162—00
20171—00
2018410500
2019419104
20200—00
20210—026
20222—047
20231—162
20243271045
2025789540
202631760—

What is it indicated for?

The BD MAX™ Enteric Parasite Panel performed on the BD MAX™ System is an automated in vitro diagnostic test for the direct qualitative detection of enteric parasitic pathogens. The BD MAX Enteric Parasite Panel detects nucleic acids from: • Giardia lamblia • Cryptosporidium (C. hominis and C. parvum only) • Entamoeba histolytica Testing is performed on unpreserved or 10% formalin-fixed stool specimens from symptomatic patients with suspected…

Read the full statement (253 words)

The BD MAX™ Enteric Parasite Panel performed on the BD MAX™ System is an automated in vitro diagnostic test for the direct qualitative detection of enteric parasitic pathogens. The BD MAX Enteric Parasite Panel detects nucleic acids from:

• Giardia lamblia

• Cryptosporidium (C. hominis and C. parvum only)

• Entamoeba histolytica

Testing is performed on unpreserved or 10% formalin-fixed stool specimens from symptomatic patients with suspected gastroenteritis, enteritis or colitis. The assay is intended to aid in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings. The test is performed directly on the specimen, utilizing real-time polymerase chain reaction (PCR) for the amplification of specific targets. The test utilizes fluorogenic gene-specific hybridization probes for detection of the amplified DNA.

This test is intended for use, in conjunction with clinical presentation, laboratory findings, and epidemiological information, as an aid in the differential diagnosis of Giardia lamblia, Cryptosporidium hominis and C. parvum, as well as Entamoeba histolytica infections. Results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decision. Positive results do not rule out co-infection with other organisms that are not detected by this test, and may not be the sole or definitive cause of patient illness. Negative results in the setting of clinical illness compatible with gastroenteritis and/or colitis may be due to infection by pathogens that are not detected by this test or non-infectious causes such as ulcerative colitis, irritable bowel syndrome, or Crohn’s disease.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K143648: BD MAX Enteric Parasite Panel, BD MAX Instrument.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K143648

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026